ArticleBMC psychiatry2026
Immune-metabolic dysregulation and suicide risk in adolescents with major depressive disorder: a cross-sectional study.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiomarkers distinguishing suicidal from non-suicidal adolescents with major depressive disorder (MDD) remain elusive. This study investigated immune-metabolic dysregulation and its predictive utility for suicide attempt (SA) risk in medication-naïve adolescents.
methodsA case-control study compared 168 non-suicidal MDD adolescents with 96 MDD + SA adolescents (recent SA). Peripheral biomarkers included immune cell ratios (neutrophil/HDL [NHR], monocyte/HDL [MHR], lymphocyte/HDL [LHR]), metabolic markers (triglycerides, HDL-C, total protein (TP)), and hematological indices. Analyses employed group comparisons (t-tests/Mann-Whitney U), Spearman correlations, binary logistic regression, and ROC analysis.
resultsThe groups were well-matched demographically and for clinical severity. After adjusting for covariates, the MDD + SA group exhibited significant immune-metabolic dysregulation, including granulocyte hyperactivity, elevated inflammatory ratios, profound HDL-C depletion, hypertriglyceridemia, and reduced total protein (all key findings with adjusted p < 0.05). A post-hoc False Discovery Rate analysis confirmed the robustness of the core lipid findings. Binary logistic regression, adjusted for age, sex, and BMI, identified triglycerides (adjusted OR = 2.17 per mmol/L) and total protein (adjusted OR = 0.93 per g/L decrease) as independent predictors of SA. A model combining triglycerides and total protein significantly outperformed individual biomarkers in ROC analysis (AUC = 0.74, 95% CI: 0.68-0.80).
conclusionsConvergent lipid-protein dysregulation represents a novel pathway for adolescent SA risk, identifiable as a significant shift within the normal laboratory range. A simple two-biomarker panel shows promise for risk stratification but requires future validation. These findings highlight metabolic dysfunction as a potential target for preventive strategies, though they do not yet constitute evidence for specific clinical interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.